Research aim Sample Clauses

Research aim. It is surprising that with agreement problems being central to so many domains that there exists very little study of agreement problems in general. While there is much work in specific domains, there exists very little work that characterizes the space of agreement problems and identifies the critical issues that make agreement problems difficult: that is, there is no general theory of of agreement problems. The broad aim of this research is to develop a general theory of agreement problems which must, we believe, be oriented around the central issues of information gathering and information use. A general theory of MAPs should answer the following questions:
Sample 1
AutoNDA by SimpleDocs
Research aim. In the present study we aimed to contribute to the existing literature by providing further insight into the importance of specific characteristics of induction programs concerning the well-being of beginning teachers. For this purpose we conducted a survey study amongst be- ginning teachers, which provides the opportunity to compare the effects of induction programs with different characteristics. Also, items about the ways in which beginning teachers experi- enced their school culture and several personal variables were included, which enabled us to gain further insight into the relative importance of an induction program. We aimed to answer the following research questions: 1 What is the degree of the state of well-being of beginning teachers? 3 How do characteristics of the induction program relate to the well-being of beginning teachers?
Sample 1
Research aim. The primary focus is to evaluate the similarities between chordomas and chordoma-like tumors and to continue to characterize the chordoma-like tumors in zebrafish so we may better understand their mechanism of formation in addition to identifying possible drug targets. Specifically, the genes TGF-β2, TGF-β3, DRAKR1b1, and DRAKR1b10 were investigated. The roles and expression of these gene products were studied via in situ hybridization. Due to difficulties obtaining embryos, less laboratory work was completed than expected. For this reason, this thesis is a combination of laboratory and literature-based research. The Purpose of In situ Hybridization Different cells express different genes. Which genes are expressed in any cell depends on the stage of development. To better characterize the chordoma-like tumors and to understand how they are formed, it is important to know when and where genes are expressed. The Purpose of Studying TGF-β2,3 It is not known exactly how SB-505124 interacts with the nodal/TGF-β pathway to cause chordoma-like tumors. This drug is known to inhibit this pathway which is used by several ligands including nodal and TGF-β2,3, however, if it not known which of these ligands is being blocked at the time of the drug administration that results in tumor formation. The purpose of my research this year has been to better characterize the formations of these tumors so we may understand potential drug targets. Nodal is not expressed when the drug is administered, therefore it is likely not what is being blocked to cause tumor formation. As mentioned, nodal is required for formation of the chordamesoderm, thus early treatment of embryos with SB-505124 leads to a loss of these notochord precursor cells. However, drug treatment at a later stage of development, at 15-16 hpf, leads to chordoma-like tumor formation. Nodal, one of the ligands blocked by the drug, is not active at this time. We have looked at the ZFin database to examine other ligands that are expressed in the correct timeframe. TGF-β2,3 are active at this time, therefore, it is believed chordoma-like tumor formation is a result of the blockage of TGF-β, not nodal. It is likely TGF-β signaling is required for terminal differentiation of the notochord, similar to the anti-growth role TGF-β plays in epithelial cells (Seoane 2006). For this reason, TGF-β2,3 are RNA targets of interest for in situ hybridization. If in situ expression patterns in chordoma-like tumors support the theory ...
Sample 1
Research aim. The aim of this research is to contextualize the content and meaning of constructs like women’s empowerment, particularly the enabling resources at women’s disposal that influence Qatari women’s perception of their mental health and well-being during pregnancy. The following research questions were developed to explore these constructs:
Sample 1

Related to Research aim

  • Technology Research Analyst Job# 1810 General Characteristics Maintains a strong understanding of the enterprise’s IT systems and architectures. Assists in the analysis of the requirements for the enterprise and applying emerging technologies to support long-term business objectives. Responsible for researching, collecting, and disseminating information on emerging technologies and key learnings throughout the enterprise. Researches and recommends changes to foundation architecture. Supports research projects to identify and evaluate emerging technologies. Interfaces with users and staff to evaluate possible implementation of the new technology in the enterprise, consistent with the goal of improving existing systems and technologies and in meeting the needs of the business. Analyzes and researches process of deployment and assists in this process.

  • Research Use The Requester agrees that if access is approved, (1) the PI named in the DAR and (2) those named in the “Senior/Key Person Profile” section of the DAR, including the Information Technology Director and any trainee, employee, or contractor1 working on the proposed research project under the direct oversight of these individuals, shall become Approved Users of the requested dataset(s). Research use will occur solely in connection with the approved research project described in the DAR, which includes a 1-2 paragraph description of the proposed research (i.e., a Research Use Statement). Investigators interested in using Cloud Computing for data storage and analysis must request permission to use Cloud Computing in the DAR and identify the Cloud Service Provider (CSP) or providers and/or Private Cloud System (PCS) that they propose to use. They must also submit a Cloud Computing Use Statement as part of the DAR that describes the type of service and how it will be used to carry out the proposed research as described in the Research Use Statement. If the Approved Users plan to collaborate with investigators outside the Requester, the investigators at each external site must submit an independent DAR using the same project title and Research Use Statement, and if using the cloud, Cloud Computing Use Statement. New uses of these data outside those described in the DAR will require submission of a new DAR; modifications to the research project will require submission of an amendment to this application (e.g., adding or deleting Requester Collaborators from the Requester, adding datasets to an approved project). Access to the requested dataset(s) is granted for a period of one (1) year, with the option to renew access or close-out a project at the end of that year. Submitting Investigator(s), or their collaborators, who provided the data or samples used to generate controlled-access datasets subject to the NIH GDS Policy and who have Institutional Review Board (IRB) approval and who meet any other study specific terms of access, are exempt from the limitation on the scope of the research use as defined in the DAR.

  • Research Support opioid abatement research that may include, but is not limited to, the following:

  • Research, Science and Technology Cooperation 1. The aims of cooperation in research, science and technology, carried out in the mutual interest of the Parties and in compliance with their policies, will be: (a) to build on existing agreements already in place for cooperation on research, science and technology; (b) to encourage, where appropriate, government agencies, research institutions, universities, private companies and other research organizations in the Parties to conclude direct arrangements in support of cooperative activities, programs or projects within the framework of this Agreement, specially related to trade and commerce; and (c) to focus cooperative activities towards sectors where mutual and complementary interests exist, with special emphasis on information and communication technologies and software development to facilitate trade between the Parties. 2. The Parties will encourage and facilitate, as appropriate, the following activities including, but not limited to:

  • Research Design The data generated by excavations at the prehistoric site(s) will be used to examine at least three topics: (1) chronology; (2) technology; and (3) subsistence practices. Insights into changing patterns of community organization may also be granted, as may insights into changes in social organization. The data recovered will then be compared to data from other regional sites.

  • Collaboration We believe joint effort toward common goals achieves trust and produces greater impact for L.A. County’s youngest children and their families.

  • Clinical Trials The studies, tests and preclinical and clinical trials conducted by or on behalf of, or sponsored by, the Company, or in which the Company has participated, that are described in the Registration Statement, the Time of Sale Disclosure Package or the Prospectus, or the results of which are referred to in the Registration Statement, the Time of Sale Disclosure Package or the Prospectus, were and, if still pending, are being conducted in all material respects in accordance with protocols, procedures and controls pursuant to, where applicable, accepted professional and scientific standards for products or product candidates comparable to those being developed by the Company and all applicable statutes, rules and regulations of the FDA, the EMEA, Health Canada and other comparable drug and medical device (including diagnostic product) regulatory agencies outside of the United States to which they are subject; the descriptions of the results of such studies, tests and trials contained in the Registration Statement, the Time of Sale Disclosure Package or the Prospectus do not contain any misstatement of a material fact or omit a material fact necessary to make such statements not misleading; the Company has no knowledge of any studies, tests or trials not described in the Disclosure Package and the Prospectus the results of which reasonably call into question in any material respect the results of the studies, tests and trials described in the Registration Statement, the Time of Sale Disclosure Package or Prospectus; and the Company has not received any notices or other correspondence from the FDA, EMEA, Health Canada or any other foreign, state or local governmental body exercising comparable authority or any Institutional Review Board or comparable authority requiring or threatening the termination, suspension or material modification of any studies, tests or preclinical or clinical trials conducted by or on behalf of, or sponsored by, the Company or in which the Company has participated, and, to the Company’s knowledge, there are no reasonable grounds for the same. Except as disclosed in the Registration Statement, the Time of Sale Disclosure Package and the Prospectus, there has not been any violation of law or regulation by the Company in its respective product development efforts, submissions or reports to any regulatory authority that could reasonably be expected to require investigation, corrective action or enforcement action.

  • Develop programs 1) The Employer will develop and implement health promotion and health education programs, subject to the availability of resources. Each Appointing Authority will develop a health promotion and health education program consistent with the Minnesota Management & Budget policy. Upon request of any exclusive representative in an agency, the Appointing Authority shall jointly meet and confer with the exclusive representative(s) and may include other interested exclusive representatives. Agenda items shall include but are not limited to smoking cessation, weight loss, stress management, health education/self-care, and education on related benefits provided through the health plan administrators serving state employees.

  • Research Project 3.1 These Materials and Data will be used by Recipient's PI solely in connection with the Research Project, as named and described in the attached research application (insert Research Project name below):

  • Commercialization Intrexon shall have the right to develop and Commercialize the Reverted Products itself or with one or more Third Parties, and shall have the right, without obligation to Fibrocell, to take any such actions in connection with such activities as Intrexon (or its designee), at its discretion, deems appropriate.

Time is Money Join Law Insider Premium to draft better contracts faster.